Traitements2programmes
Essais1liés
Publications2liées
SourceDBlocale

Traitements

2
MoléculeIndication / populationPhaseObjectifPaysRésultat
UwmBmmscALS — Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Patients With Amyotrophic Lateral SclerosisDescription non affichée : incohérence de maladie détectée. Consultez l’essai clinique officiel associé. Sclérose latérale amyotrophique Phase 1 Thérapie cellulaire À vérifier
UwmBmmscALS — Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Patients With Amyotrophic Lateral SclerosisDescription non affichée : incohérence de maladie détectée. Consultez l’essai clinique officiel associé. Sclérose latérale amyotrophique Phase 1 Thérapie cellulaire À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
UwmBmmscALS — Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Patients With Amyotrophic Lateral Sclerosis Sclérose latérale amyotrophique Phase 1 NCT02881489 UwmBmmscALS — Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Patients With Amyotrophic Lateral Sclerosis UNKNOWN

Publications

2
MoléculeIndication / populationTitreJournalDate
UwmBmmscALS — Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Patients With Amyotrophic Lateral Sclerosis Unraveling the Potential of Stem Cell Therapy in Motor Neuron Disease: A Narrative Review. CNS & neurological disorders drug targets
UwmBmmscALS — Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Patients With Amyotrophic Lateral Sclerosis Adipose-derived mesenchymal stem cells for the treatment of Amyotrophic Lateral Sclerosis. A phase I/II safety and efficacy clinical trial. Frontiers in neurology